Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793602
Max Phase: Preclinical
Molecular Formula: C19H28F2NO5P
Molecular Weight: 419.41
Molecule Type: Unknown
Associated Items:
ID: ALA4793602
Max Phase: Preclinical
Molecular Formula: C19H28F2NO5P
Molecular Weight: 419.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C/C(=C\CC(F)(F)P(=O)(N[C@@H](C)C(=O)OC(C)(C)C)Oc1ccccc1)CO
Standard InChI: InChI=1S/C19H28F2NO5P/c1-14(13-23)11-12-19(20,21)28(25,27-16-9-7-6-8-10-16)22-15(2)17(24)26-18(3,4)5/h6-11,15,23H,12-13H2,1-5H3,(H,22,25)/b14-11+/t15-,28?/m0/s1
Standard InChI Key: SVNXVFMFYNGNIB-BRUKFHTCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 419.41 | Molecular Weight (Monoisotopic): 419.1673 | AlogP: 4.50 | #Rotatable Bonds: 9 |
Polar Surface Area: 84.86 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.89 | CX Basic pKa: | CX LogP: 2.95 | CX LogD: 2.95 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.35 | Np Likeness Score: 0.35 |
1. Kadri H,Taher TE,Xu Q,Sharif M,Ashby E,Bryan RT,Willcox BE,Mehellou Y. (2020) Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses., 63 (19.0): [PMID:32930595] [10.1021/acs.jmedchem.0c01232] |
Source(1):